ReviewJournal of clinical medicine2026

Advances in First-Line Treatment of Classical Hodgkin Lymphoma in the Era of Novel Agents.

Ahmed Salleh BarefahPubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.